Aprax Suspension
Flavored Suspension
Veterinary Use
Aprax. Flavored Suspension. Broad spectrum internal antiparasitic for dogs and cats. Efficacy proven in one shot. (*)
(*) Efficacy tests carried out in the Department of Parasitological and Parasitic diseases for the Faculty of Veterinary Science.
Formula:
Fenbendazole 5,00 g
Praziquantel 0,50 g
Pyrantel (as Pamoate) (**) 0,50 g
Excipients q.s.f 100,00 mL
**Equivalent to 1,44 g of Pyrantel pamoate
Indications
Aprax is a broad spectrum internal antiparasitic, indicated for the control of gastrointestinal parasitosis in dogs and cats, caused by nematodes and cestodes.
Nematodes: Toxocara canis and cati, Toxascaris leonina, Ancylostoma caninum, Ancylostoma tubaeforme, Uncinaria stenocephala; Strongyloides stercoralis; Trichuris vulpis; Physaloptera sp.
Cestodes: Taenia spp, Dipylidium caninum.
The efficacy tests performed with Aprax in dogs and cats demonstrate a power of action on flat and round worms greater than 98%.
Orientative Dosage
Flavored suspension for oral use only.
Shake the product before use
Dogs and Cats: 1 mL/kg/day orally
Equivalent to:
Fenbendazole 50 mg/kg/day
Praziquantel 5 mg/kg/day
Pyrantel 5 mg/kg/day
Administer the total calculated dose of the product in a single dose.
In case of severe infestations, the total dose calculated for the animal may be administered for three days in a row.
This same dosing schedule should be repeated again 15-21 days after the first treatment.
A preventive systematic deworming plan can also be implemented every 60-90 days.
The interval between doses may be modified by the acting veterinarian according to the particular case.
Aprax can be used in pregnant females from the 40th day of pregnancy, in puppies from 30 days of age and in kittens more than 6 weeks old.
Contraindications and Use Limitations
Anorexy, vomiting, lethargy and diarrhea can occur in dogs. However the incidence of these effects is less than 5%
In cats, adverse effects (salivation, vomiting and diarrhea) are very rare, less than 2%.
Hypersensitive reactions secondary to the release of antigens can occur due to the death of parasites. This happens particularly when the product is administered in high doses
Incompatibilities: do not administer the product with morantel, levamisole, organophosphorus, diethylcarbamycin or piperazine.
Precautions
Do not administer in very weakened animals, or in situations of intense stress
Verify that the product inviolability system and its storage conditions prior its use are adequate, as well as that it has not expired in reference to the expiration date expressed on the label.
Verify that the product is administered exclusively orally. Do not exceed the propose dose.
The suggested dose and warnings in all cases are for the consideration of the acting veterinarian
